11 January 2022 in Hepatology Communications
Transforming growth factor beta (TGF‐β) signaling in hepatocytes promotes steatosis and body weight gain. However, processes that TGF‐β signaling in hepatocytes promote pathological body weight gain in nonalcoholic fatty liver disease (NAFLD) are incompletely understood. Obesity and NAFLD were induced by 16 weeks of feeding a high‐fat diet (HFD) in hepatocyte‐specific TGF‐β receptor II–deficient ( Tgfbr2ΔHEP ) and Tgfbr2flox/flox mice. In addition, browning of white adipose tissue (WAT) was induced by administration of CL‐316,243 (a β3‐adrenergic agonist) or cold exposure for 7 days. Compared with Tgfbr2 flox/flox mice, Tgfbr2ΔHEP mice were resistant to steatosis and obesity. The metabolic changes in Tgfbr2ΔHEP mice were due to the increase of mitochondrial oxidative phosphorylation in the liver and white‐to‐beige fat conversion. A further mechanistic study revealed that exosomal let‐7b‐5p derived from hepatocytes was robustly elevated after stimulation with palmitic acid and TGF‐β. Indeed, let‐7b‐5p levels were low in the liver, serum exosomes, inguinal WAT, and epididymal WAT in HFD‐fed Tgfbr2ΔHEP mice. Moreover, 3T3‐L1 cells internalized hepatocyte‐derived exosomes. An in vitro experiment demonstrated that let‐7b‐5p overexpression increased hepatocyte fatty acid transport and inhibited adipocyte‐like cell thermogenesis, whereas let‐7b‐5p inhibitor exerted the opposite effects. Conclusion: Hepatocyte TGF‐β‐let‐7b‐5p signaling promotes HFD‐induced steatosis and obesity by reducing mitochondrial oxidative phosphorylation and suppressing white‐to‐beige fat conversion. This effect of hepatocyte TGF‐β signaling in metabolism is partially associated with exosomal let‐7b‐5p.
19 February 2022 in Hepatology
TCthe Chinese AIH Consortium
the Chinese AIH Consortium
+37
14 June 2018 in IEEE Transactions on Components, Packaging and Manufacturing Technology
In this paper, a high-resistivity silicon (HR-Si) interposer integrated with through-silicon via (TSV) electrically grounded coplanar waveguide (CPW) line is presented for 2.5-D/3-D heterogeneous integration of radio frequency (RF) microelectronics devices. In addition, design of TSV interconnection composed of two coaxial ladder-hollow-annular Cu (copper) TSVs of different diameters is utilized to maintain a sufficient freedom for strict standard cleaning to avoid Si resistivity degradation. The formation of the coaxial ladder TSV structure is more beneficial to the subsequent plating process because it reduces the aspect ratio of TSV vias. Hollow-annular Cu TSV is manufactured in order to reduce the problem of mismatch in coefficient of thermal expansion among TSV's constituent materials. A layer of Au (aurum) film is utilized to passivate the exposed Cu surface of Si interposer. Au is widely used in III-V groups' devices because of the good compatibility with photonic integrated circuits, conductivity, and corrosion resistance. HR-Si interposer with TSV grounded CPW line and test structure is fabricated and characterized. With the monitoring test results, it can be found that it changes little in the resistivity of Si substrate, though the whole process, which is a basic requirement for RF performance. RF property test results show that the insertion loss is about -0.20 dB/mm at 10 GHz for the presented TSV grounded CPW line and -0.02 dB per TSV. These test results are better than the traditional design. To verify its applicability to 2.5-D/3-D heterogeneous integration, RF microelectronics die is assembled on TSV interposer and tested, and the test results prove that it works properly.
13 October 2022 in Journal of Neurochemistry
11 March 2022 in Journal of Clinical and Translational Hepatology
Hepatic sinusoidal obstruction syndrome (HSOS) is a life-threatening syndrome, and a cause is exposure to pyrrolizidine alkaloid (PA)-containing products. It is well-established that retrorsine (RTS), a representative Pas, insults hepatic sinusoidal endothelial cells and ensues congestion of hepatic sinusoids. However, little known about the impact of Pas on gut microbiota and intestinal barrier and inflammation in HSOS.